Jump to content

Chandler Park

From Wikipedia, the free encyclopedia

Chandler Park
EducationBiomedical engineeringB.S. at (University of Illinois at Urbana-Champaign)
Medical DoctorateM.D. at (University of Louisville School of Medicine)
biophysicsMSc (University of LouisvilleGraduate School)
Transitional surgeryinternshipatCleveland Clinic FoundationHealth Systems
diagnostic radiologyandinternal medicineresidency atIndiana University School of Medicine
Occupation(s)Physician,clinical researcher,medical writer

Chandler Parkis an American physician, medical journalist, andclinical researcher.[1]In June 2021, his cancer research was published in prominent medical journals including the New England Journal of Medicine[2]and Journal of Clinical Oncology.[3]Park also contributes regularly as an expert physician for popular newspapers and magazines such asNewsweek,[4]Reader's Digest,[5][6][7]U.S. News & World Report,[8]The Exponent-Telegram,[9]College of St. Scholastica,[10]andMedscape[11]and writes medical news forDoximity.[12][13]

Career

[edit]

Park is a clinical professor that teaches biochemistry, physiology, hematology, and medical oncology at the University of Louisville School of Medicine.[14]He also works as an advisory Dean at the University of Louisville School of Medicine and plays a vital role in the transition into medical school and the development into a physician.[15]Park was selected as a teaching faculty to provide new cancer information atAmerican Society of Clinical Oncology.[16]In February 2019, he helped develop the continuing medical education course titled 2019 Breast and Gynecologic Cancersfor American Society of Clinical Oncology[17]and published his continuing medical education course in Anticancer Therapeutics, Research, and Supportive Care.[18]In February 2020, he also helped develop a new continuing medical education online course for cancer physicians in America to update them on new cancer information in Hematologic Malignancies and Blood Cancers.[19]In June 2020, he was interviewed to discuss CAR-T Cell and provided information on upcoming treatments for CAR-T cell.[20]

Park is also one of the contributing authors of the book, Lung Cancer: Standards of Care[21]that discusses diagnosis and treatment of lung cancers released in December 2020.[22]Park was also interviewed by Targeted Oncology on Kidney Cancer Treatments in February 2021.[23]

In 2020, Park was selected as the President of the Kentucky Society of Clinical Oncology.[24]The Kentucky Society of Clinical Oncology is the state affiliate ofAmerican Society of Clinical Oncology,American Society of Hematology,andNational Cancer Institute.

He has been interviewed by leading cancer media digital media including Cure Magazine,[25][26]Targeted Oncology,[27][28]Urology Times,[29]and OncLive[30][31][32]in 2023.

Journalism

[edit]

Park writes medical columns for Medscape[33]and Doximity Op(m)ed.[34]He writes articles on medical education and cancer news.[35]His medical education writings include The Hidden Curriculum: How to Avoid Being Labeled a Problem Resident.[36]He has also written cancer news at the American Society of Clinical Oncology and American Society of Hematology annual meetings,[37][38][39]and has volunteered on the editorial board of Journal ofHospital Practiceand helps select cancer journal articles for hospital physicians.[40]Park is the founder of Cancervisit a company dedicated to helping cancer patients and their families.[41]In April 2020, Park was interviewed by theAmerican College of Physicianson ways medical students can prepare for residency training.[42]

Park also provides video medical updates for physicians on IMDb[43]and YouTube.[44]He has written cancer updates in kidney cancer with Toni Choueiri,[45]prostate cancer with Neeraj Agarwal,[46]and Bladder Cancer with Petros Grivas[47]

Education

[edit]

Park received a Bachelor of Science degree inBiomedical EngineeringandBiochemistryfromUniversity of Illinois at Urbana-Champaignand hisDoctor of Medicinedegree from theUniversity of Louisville School of Medicine.He also acquired medical science research training at theUniversity of LouisvilleinLouisville, Kentuckyand received a master's degree in science inbiophysics.

After his medical school and graduate school research training, Park served his surgery transitionalinternshipatCleveland Clinic FoundationHealth Systems. Next, he did hisresidencytraining indiagnostic radiologyandinternal medicineatIU Medical Center.Afterwards he finished subspecialist medical training in Hematology and Oncology at WVU Cancer Institute and received additional medical training as avisiting fellowat University of Pittsburgh incancer immunotherapy.[48]

He is a practicing cancer physician at Norton Cancer Institute and a physician member of the molecular tumor board at theUniversity of KentuckyMarkey Cancer Center.[49]Park is triple-board-certified ininternal medicine,hematologyandoncology.[50]

Research

[edit]

Park has participated in multiple cancer clinical trials in lung, melanoma, thyroid, and bone marrow transplant. He has been nationally recognized as an exceptional doctor by his physician colleagues and was given an honorary title as a distinguished fellow of theAmerican College of Physicians(FACP) for providing outstanding patient care and significant medical research contributions.[51]

Park has written cancer papers about PET/CT and regional brain metabolic changes associated with depression in metastatic breast cancer,[52]sorafenib and thyroid cancer,[53]pemetrexed-based chemotherapy in lung cancer,[54]atypical neurolymphomatosis,[55]metformin use and allogenic stem cell transplant,[56]and decreased cancer rates.[57]

Park's medical research also included anMRIstudy that usedviscoelasticpads to improve patient care duringMRIstudies. His research group developed the patentedviscoelasticpads used by many of the currentMRItables.[58]Theviscoelasticpads decreaseischemia,pain,and discomfort for patients undergoingMRIstudies. His MRI research led to improved quality of theMRIimaging studies to improvepatient care,[59]He has also studied the effect ofnicotineon bone arteriole blood flow.[60]

He also volunteers on the editorial board of Journal ofHospital Practiceand helps select cancer journal articles for hospital physicians.[61]

Public speaking

[edit]

After his landmark MRI study was published, Park has been a live public speaker at large medical society meetings includingAmerican Society for Therapeutic Radiology and Oncology,andRadiological Society of North America.[62]He was invited as a speaker to discuss "Designing Continuing Professional Development that improves patients care: Insights from a Practicing Oncologist" at the annual Alliance for Continuing Education meeting in Orlando, Florida.[63]In July 2018, he was interviewed by healthcare industry leading magazine Managed Health Care Executive on Five Ways Health Execs Can improve Lymphoma Treatment.[64]

In January 2020, he gave a live oral presentation to the Alliance of Continuing Medical Education for Healthcare Providers to improve cancer care by medical oncologists by discussing the importance of shared decision making with physicians, patients, nurses, patients' families, pharmacists, and the entire clinical care team.[65]He also co-hosted a medical education program for the Society for Immunotherapy of Cancer that discussed Advances in Cancer Immunotherapy on December 10, 2020.[66]

Park has been chosen as a Castle Connolly Top Doctor[67]in Cancer by his physician peers in 2019,[68]2020,[69]and 2021.[70]In 2021, Park was recognized as one of the 3 best oncologists in Louisville, Kentucky by Three Best Rated.[71]

Park has also been recognized by the American Registry company with patient care awards in Patient's choice[72]and Compassionate Doctor.[73]In June 2020, he received the 5 year Patient's Choice award as one of Kentucky's Favorite Physicians[74]and top 1% of America's Most Honored Doctors.[75]

Authored works

[edit]
  • Fleming, J. T.; Lobo, S. A.; Park, C. H.; Gordon, S. A.; Roberts, C. S.; Rowell, P. P. (2008). "Nicotine does not reduce blood flow to healthy bone in rats".American Journal of Orthopedics (Belle Mead, N.J.).37(7): E129–32.PMID18795191.
  • Park, Chandler; Perini, Jessica; Farmer, Roger W.; Fancy, Tanya; Monga, Manish; Remick, Scot C (2014). "Sorafenib and Thyroid Cancer".Expert Review of Endocrinology & Metabolism.9(6): 561–570.doi:10.1586/17446651.2014.960391.PMID30736194.S2CID56683794.
  • C. Park, M. Almubarak, K. Patel, J. Flannery, M. Haut, G. Hobbs, G. Marano. "PET/CT and Regional Brain Metabolic Changes Associated with Depression in Metastatic Breast Cancer." Presentation at American Society of Clinical Oncology June 2016
  • Alshehri, A.; Alsubait, S.; Alamgir, M.; Park, C.; Wen, S.; Luo, J.; Ma, P.; Monga, M. (2015). "Pemetrexed-based chemotherapy in advanced nonsquamous non-small cell lung cancer (NSCLC)".Journal of Clinical Oncology.33(15_suppl): e22245.doi:10.1200/jco.2015.33.15_suppl.e22245.
  • Khimani, F.; Park, C.; Monga, M.; Hobbs, G.; Leadmon, S.; Basu, S. (2014). "Metformin use and allogeneic stem cell transplant (ASCT) outcomes".Journal of Clinical Oncology.32(15_suppl): 18001.doi:10.1200/jco.2014.32.15_suppl.e18001.
  • Murray, A.; Bittner, F.; Gyure, K.; Park, C.; Addocks, A. (2015)."An Atypical Presentation of Neurolymphomatosis: A case report and literature review".Neurology.84(14S): P2.012.
  • C. Park, J. Caverney, T. Hogan. "Sunitinib As the 'Second Hit' In Acute Esophageal Necrosis." American College of Physicians. American College of Physicians: Research Presentation October 2014.
  • C. Park, A. Almustafa, S. Basu. "Recurrent Decompensated Heart Failure Due to Multiple Myeloma Associated Amyloidosis." American College of Physicians. Research Presentation. October 2014.
  • C. Park, N. Moka, M. Monga. "Acquired Hemophilia in a Patient with Hepatocellular Carcinoma." American College of Physicians. Research Presentation. October 2014.
  • C. Park, A. Husain "PET scan negative metastatic chondrosarcoma," American College of Physicians. Research Presentation. October 2011 ACP Annual Meeting.
  • C. Park, J. Massey, I. Koury, P. Rothschild. "Use of pressure relieving viscoelastic MRI pads to reduce patient motion and callbacks." Oral Research Presentation 2006 Radiological Society of North America, November 2006.

References

[edit]
  1. ^"Molecular Tumor Board".UK HealthCare.RetrievedDecember 23,2023.
  2. ^Sartor, Oliver; Bono, Johann de; Chi, Kim N.; Fizazi, Karim; Herrmann, Ken; Rahbar, Kambiz; Tagawa, Scott T.; Nordquist, Luke T.; Vaishampayan, Nitin; El-Haddad, Ghassan; Park, Chandler H. (June 23, 2021)."Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer".New England Journal of Medicine.385(12): 1091–1103.doi:10.1056/NEJMoa2107322.PMC8446332.PMID34161051.
  3. ^Morris, Michael J.; De Bono, Johann S.; Chi, Kim N.; Fizazi, Karim; Herrmann, Ken; Rahbar, Kambiz; Tagawa, Scott T.; Nordquist, Luke T.; Vaishampayan, Nitin; El-Haddad, Ghassan; Park, Chandler H. (May 20, 2021)."Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION)".Journal of Clinical Oncology.39(18_suppl): LBA4.doi:10.1200/JCO.2021.39.15_suppl.LBA4.ISSN0732-183X.S2CID236400202.
  4. ^"Budget cuts could lead to more radon deaths".Newsweek.April 30, 2017.RetrievedMay 3,2017.
  5. ^"Myths About What Cancer Is and Cancer Causes | Reader's Digest".Reader's Digest.RetrievedMay 3,2017.
  6. ^Andersen, Charlotte (August 12, 2017)."50 Things Your Doctor Wishes You Knew About Losing Weight".rd.com.RetrievedAugust 12,2017.
  7. ^Hilton, Charlotte; ersenDec 18."Things You Can Do Today to Lose Weight".Reader's Digest.RetrievedJanuary 5,2019.{{cite web}}:CS1 maint: numeric names: authors list (link)
  8. ^Kowarski, Ilana (January 4, 2017)."5 Things to do before applying to medical school".U.S. News & World Report.RetrievedJanuary 22,2017.
  9. ^Murray, Brittany."Cancer Prevention Month celebrated with decreased cancer rates".The Exponent Telegram.RetrievedMay 3,2017.
  10. ^"Med school requirements every healthcare hopeful should master in college".RetrievedMay 3,2017.
  11. ^Skwarecki, Beth (February 10, 2017)."Unmatched after match day – What's Next?".Medscape.RetrievedFebruary 10,2017.
  12. ^"Chandler Park, MD, FACP".opmed.doximity.com.RetrievedOctober 5,2019.
  13. ^"Doximity".doximity.com.RetrievedJanuary 5,2019.
  14. ^"Joint, Associate, & Adjunct Faculty — School of Medicine University of Louisville".louisville.edu.RetrievedApril 6,2021.
  15. ^"Advisory Deans — School of Medicine University of Louisville".louisville.edu.RetrievedApril 6,2021.
  16. ^"ASCO Faculty. Cme Information January 2018 1 » MOC".mocapp.asco.org.RetrievedApril 6,2021.
  17. ^"ASCO Faculty Cme Info 2019 Breast And Gynecologic Cancers » MOC".mocapp.asco.org.RetrievedApril 6,2021.
  18. ^"Faculty Cme Info 2019 Anticancer Therapeutics Research And Supportive Care » MOC".mocapp.asco.org.RetrievedApril 6,2021.
  19. ^"ASCO Faculty Cme Info 2020 Self Evaluation App Hematologic Malignancies » MOC".mocapp.asco.org.RetrievedApril 6,2021.
  20. ^"Developments in CAR T".Managed Healthcare Executive.RetrievedApril 6,2021.
  21. ^"Authors | Lung Cancer: Standards of Care | AccessHemOnc | McGraw-Hill Medical".hemonc.mhmedical.com.RetrievedApril 6,2021.
  22. ^Kloecker, Goetz; Fraig, Mostafa; Arnold, Susanne M.; Perez, Cesar A. (December 7, 2020).Lung Cancer: Standards of Care.ISBN978-1260136203.
  23. ^"Park Discusses Targeted Therapy Trials in Intermediate- and High-Risk ccRCC".Targeted Oncology.RetrievedApril 6,2021.
  24. ^"Kentucky Society of Clinical Oncology Board of Trustees".kaomo.wildapricot.org.RetrievedAugust 15,2020.
  25. ^"Advice for Patients with Advanced Renal Cell Carcinoma".Curetoday.October 25, 2023.RetrievedDecember 23,2023.
  26. ^"Combination Immunotherapy for Treating Advanced Renal Cell Carcinoma".Curetoday.October 18, 2023.RetrievedDecember 23,2023.
  27. ^"Recent Trial Updates in Advanced Renal Cell Carcinoma (RCC)".Targeted Oncology.March 31, 2023.RetrievedDecember 23,2023.
  28. ^"Adjuvant Pembrolizumab in Patients with Clear-cell Renal Cell Carcinoma".Targeted Oncology.March 3, 2023.RetrievedDecember 23,2023.
  29. ^"Dr. Park on the ARASENS and TITAN trials in mHSPC".Urology Times.April 14, 2023.RetrievedDecember 23,2023.
  30. ^"Dr. Park on the Increasing Use of Biomarker Testing and Radiotheranostics in Prostate Cancer".OncLive.March 6, 2023.RetrievedDecember 23,2023.
  31. ^"AR Pathway Inhibitors, ADCs, and IO/TKI Combinations Shape Standard Therapy in GU Cancers".OncLive.February 24, 2023.RetrievedDecember 23,2023.
  32. ^"Dr Park on Navigating of Later-line Treatment Options in Metastatic Urothelial Carcinoma".OncLive.May 9, 2023.RetrievedDecember 23,2023.
  33. ^Skwarecki, Beth (February 10, 2017)."Unmatched After Match Day – What's Next?".medscape.com.
  34. ^"Doximity Op-(m)ed".n.d.
  35. ^"Chandler Park | Freelance Journalist | Muck Rack".muckrack.com.RetrievedApril 6,2021.
  36. ^Park, Chandler (August 29, 2017)."How to Avoid being labeled a Problem Resident".opmed.doximity.com.RetrievedAugust 29,2017.
  37. ^Park, Chandler (June 3, 2017)."Breaking News Coverage from ASCO".doximity.com.RetrievedJune 3,2017.
  38. ^Park, Chandler (December 13, 2017)."Practice-Changing Update for Newly Diagnosed Stage III or Stage IV Hodgkin's Lymphoma Patients".doximity.com.RetrievedDecember 13,2017.
  39. ^"ASH 2018: Research That Will Make a Difference for Tomorrow's Oncologist".opmed.doximity.com.RetrievedJanuary 5,2019.
  40. ^"Hospital Practice".tandfonline.com.RetrievedMay 3,2017.
  41. ^"Cancervisit".cancervisit.com.RetrievedJuly 3,2016.
  42. ^Fishburn, Whitney."Matched, sorted: Tips to transition from student to resident".acpinternist.org.RetrievedApril 6,2021.
  43. ^"Chandler Park".IMDb.RetrievedApril 6,2021.
  44. ^Doximity Physician Spotlight: Dr. Chandler Park,retrievedApril 6,2021
  45. ^"2020 Kidney Cancer Update with Dr. Toni Choueiri at ESMO".opmed.doximity.com.RetrievedApril 9,2021.
  46. ^"2020 Prostate Cancer Update with Dr. Neeraj Agarwal".opmed.doximity.com.RetrievedApril 9,2021.
  47. ^"2020 Bladder Cancer Review with Dr. Petros Grivas: What Every Physician Should Know".opmed.doximity.com.RetrievedApril 9,2021.
  48. ^"Dr. Chandler Park at U.S. News & World Report".health.usnews.com.n.d.RetrievedJuly 3,2016.
  49. ^University of Kentucky, Markey Cancer Center (n.d.)."Markey's Molecular Tumor Board thriving in its first year".ukhealthcare.uky.edu.RetrievedMay 3,2017.
  50. ^"Verification of Board Certifications".n.d.
  51. ^"Distinguished Physician of the American College of Physicians"(PDF).acponline.org.n.d.RetrievedJuly 3,2016.
  52. ^"PET/CT and regional brain metabolic changes associated with depression in metastatic breast cancer. (presented at 2016 ASCO Annual Meeting)".ASCO University.RetrievedJuly 3,2016.
  53. ^Park, Chandler; Perini, Jessica; Farmer, Roger W; Fancy, Tanya; Monga, Manish; Remick, Scot C (2014). "Expert Review Medical Journal: Sorafenib and Thyroid Cancer".Expert Review of Endocrinology & Metabolism.9(6): 561–570.doi:10.1586/17446651.2014.960391.PMID30736194.S2CID56683794.
  54. ^"Pemetrexed and Non Small Cell Lung Cancer at 2015 American Society of Clinical Oncology Research Papers".asco.org.
  55. ^Adcock, Amelia; Park, Chandler; Gyure, Kymberly; Bittner, Frank; Murray, Ann (April 6, 2015)."Atypical Neurolymphomatosis: How to treat".Neurology.84(14 Supplement): 2.012.
  56. ^"Metformin use and allogeneic stem cell transplant (ASCT) outcomes at 2015 American Society of Clinical Oncology Meeting".asco.org.
  57. ^Murray, Brittany (February 16, 2015)."Cancer Prevention Month celebrated with decreased cancer rates".The Exponent-Telegram.RetrievedJanuary 22,2017.
  58. ^"RSNA smorgasbord a delight. – Free Online Library".Thefreelibrary.com.
  59. ^"Study Shows Patient Comfort Systems MRI Pads Reduce Patient Motion and Exam Call-Backs: Innovative New TEMPUR Material (Developed by Tempur-Pedic Inc.) Enhances Patient Comfort According to Study to be Presented at RSNA 06"(PDF).Patientcomfortsystems.com.
  60. ^"Nicotine on bone blood flow".American Journal of Orthopedics. Archived fromthe originalon August 15, 2016.RetrievedJune 29,2016.
  61. ^"Hospital Practice Editorial Board".www.tandfonline.com.RetrievedApril 6,2021.
  62. ^"MRI Viscoelastic Pads Presentation".RSNA.org.
  63. ^Park, Chandler (January 22, 2018)."Designing CPD That Improves Patient Care: Insights From a Practicing Oncologist".eventscribe.com.RetrievedJanuary 22,2018.
  64. ^Rowh, Mark (July 2, 2018)."Five Ways Health Execs Can Improve Lymphoma Treatment".managedhealthcareexecutive.com/non-hodgkin-lymphoma/five-ways-health-execs-can-improve-lymphoma-treatment.RetrievedJuly 2,2018.
  65. ^"2020 Alliance Annual Conference".www.eventscribe.com.RetrievedApril 6,2021.
  66. ^"Advances in Cancer Immunotherapy | Louisville".www.sitcancer.org.RetrievedApril 9,2021.
  67. ^"Search Top Doctors. Find Trusted Care".Castle Connolly.RetrievedApril 9,2021.
  68. ^"Dr. Chandler H. Park - Medical Oncology - Castle Connolly Top Doctor".Castle Connolly.RetrievedApril 6,2021.
  69. ^"Castle Connolly Top Doctor in 2020".www.americanregistry.com.RetrievedApril 9,2021.
  70. ^"Castle Connolly Top Doctor in 2021".www.americanregistry.com.RetrievedApril 9,2021.
  71. ^"3 Best Oncologists in Louisville, KY - Expert Recommendations".ThreeBestRated.com.RetrievedApril 9,2021.
  72. ^"Patients Choice Award".www.americanregistry.com.RetrievedApril 6,2021.
  73. ^"Compassionate Doctor Award".www.americanregistry.com.RetrievedApril 6,2021.
  74. ^"Kentucky's Favorite Doctors".www.americanregistry.com.RetrievedApril 6,2021.
  75. ^"Top 1% of Doctors".www.americanregistry.com.RetrievedApril 6,2021.
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Chandler_Park&oldid=1191921144"